Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649
Fig. 4.

Download original image

Fig. 4. The progression-free survival of the 43 patients with metastatic CRC who received apatinib plus PD-1 blockades treatment.
CRC, colorectal cancer; PD-1, programmed cell death protein 1; PFS, progression free survival.
J Cancer Prev 2023;28:106~114 https://doi.org/10.15430/JCP.2023.28.3.106
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd